Your browser doesn't support javascript.
loading
Epidemiology of dengue fever in Guatemala.
Castillo Signor, Leticia Del Carmen; Edwards, Thomas; Escobar, Luis E; Mencos, Yolanda; Matope, Agnes; Castaneda-Guzman, Mariana; Adams, Emily R; Cuevas, Luis E.
Afiliação
  • Castillo Signor LDC; Ministerio de Salud Publica y Asistencia Social de Guatemala, Guatemala City, Guatemala.
  • Edwards T; Centre for Drugs and Diagnostics Research, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Escobar LE; Department of Fish and Wildlife Conservation, Virginia Tech, Blacksburg, VA, United States of America.
  • Mencos Y; Ministerio de Salud Publica y Asistencia Social de Guatemala, Guatemala City, Guatemala.
  • Matope A; Tropical Clinical Trials Unit. Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Castaneda-Guzman M; Department of Fish and Wildlife Conservation, Virginia Tech, Blacksburg, VA, United States of America.
  • Adams ER; Centre for Drugs and Diagnostics Research, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Cuevas LE; Centre for Drugs and Diagnostics Research, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
PLoS Negl Trop Dis ; 14(8): e0008535, 2020 08.
Article em En | MEDLINE | ID: mdl-32813703
ABSTRACT
Dengue fever occurs worldwide and about 1% of cases progress to severe haemorrhage and shock. Dengue is endemic in Guatemala and its surveillance system could document long term trends. We analysed 17 years of country-wide dengue surveillance data in Guatemala to describe epidemiological trends from 2000 to 2016.Data from the national dengue surveillance database were analysed to describe dengue serotype frequency, seasonality, and outbreaks. We used Poisson regression models to compare the number of cases each year with subsequent years and to estimate incidence ratios within serotype adjusted by age and gender. 91,554 samples were tested. Dengue was confirmed by RT-qPCR, culture or NS1-ELISA in 7097 (7.8%) cases and was IgM ELISA-positive in 19,290 (21.1%) cases. DENV1, DENV2, DENV3, and DENV4 were detected in 2218 (39.5%), 2580 (45.9%), 591 (10.5%), and 230 (4.1%) cases. DENV1 and DENV2 were the predominant serotypes, but all serotypes caused epidemics. The largest outbreak occurred in 2010 with 1080 DENV2 cases reported. The incidence was higher among adults during epidemic years, with significant increases in 2005, 2007, and 2013 DENV1 outbreaks, the 2010 DENV2 and 2003 DENV3 outbreaks. Adults had a lower incidence immediately after epidemics, which is likely linked to increased immunity.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue Tipo de estudo: Incidence_studies / Prognostic_studies / Screening_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País como assunto: America central / Guatemala Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue Tipo de estudo: Incidence_studies / Prognostic_studies / Screening_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País como assunto: America central / Guatemala Idioma: En Ano de publicação: 2020 Tipo de documento: Article